Novartis Fights Bid For Sanctions Over Remand Issue
Novartis has lashed out at a bid by two plaintiffs in the Aredia and Zometa litigation over their bid to sanction the pharmaceutical company for refusing to remand their cases to...To view the full article, register now.
Already a subscriber? Click here to view full article